Supplemental Figures from MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

Autor: José Baselga, Andrew Koustenis, Martin Frenzel, Denise A. Yardley, Esther Zamora, Joyce O'Shaughnessy, Clifford A. Hudis, Hans Wildiers, Debra Patt, Véronique Diéras, Javier Cortés, Hope S. Rugo, Sara M. Tolaney, Maura N. Dickler
Rok vydání: 2023
Popis: Supplemental Figure 1. Study Design and Patient Disposition Supplemental Figure 2. Change in serum creatinine by visit Supplemental Figure 3. Change in blood urea nitrogen (BUN) by visit Supplemental Figure 4. Maximum observed value in cystatin C by visit Supplemental Figure 5. Minimum Observed Value in Neutrophils by Visit
Databáze: OpenAIRE